A
Aralex
Aachen research explorer
Sign in
Menu
Papers
Authors
Topics
Journals
Patents
Institutions
Departments
Sign in
Papers
Authors
Topics
Journals
Patents
Organizations
Institutions
Departments
Unit
Janssen (Netherlands)
Janssen Vaccines & Prevention
▲
Sign in to save
150 authors · 611 authorships ·
All papers →
People
146
Search
Sort
Most cited
h-index
Aachen papers
Name
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
▲
Hanneke Schuitemaker
Johnson & Johnson (Netherlands)
Immunology and Microbiology
31.1k
citations
88
h-index
85
Aachen papers
▲
JERALD C. SADOFF
Johnson & Johnson (Netherlands)
Immunology and Microbiology
25.2k
citations
76
h-index
52
Aachen papers
▲
Peter W. M. Hermans
Utrecht University
·
University Medical Center Utrecht
Medicine
19.3k
citations
69
h-index
4
Aachen papers
▲
JAN T. POOLMAN
Johnson & Johnson (Netherlands)
Immunology and Microbiology
15.3k
citations
67
h-index
33
Aachen papers
▲
Gert C. Scheper
Johnson & Johnson (Netherlands)
Neuroscience
9.87k
citations
45
h-index
18
Aachen papers
▲
Veronica V. Rezelj
Johnson & Johnson (United States)
·
Janssen (Netherlands)
Medicine
8.78k
citations
21
h-index
5
Aachen papers
▲
Macaya Douoguih
Johnson & Johnson (Netherlands)
Medicine
8.4k
citations
35
h-index
63
Aachen papers
▲
Maria Grazia Pau
Johnson & Johnson (Netherlands)
Medicine
7.5k
citations
40
h-index
16
Aachen papers
▲
Ronald Vogels
Johnson & Johnson (United States)
·
Johnson & Johnson (Netherlands)
Biochemistry, Genetics and Molecular Biology
7.24k
citations
36
h-index
4
Aachen papers
▲
Ludo Lavreys
Medicine
7.2k
citations
45
h-index
3
Aachen papers
▲
Johan Van Hoof
Medicine
7.11k
citations
21
h-index
18
Aachen papers
▲
Roland C. Zahn
Johnson & Johnson (United States)
·
Janssen (Netherlands)
Medicine
7.05k
citations
33
h-index
59
Aachen papers
▲
Johannes P. M. Langedijk
Medicine
6.92k
citations
40
h-index
33
Aachen papers
▲
Pei-Ling Chu
Johnson & Johnson (United States)
Medicine
6.59k
citations
10
h-index
1
Aachen papers
▲
Jenny Hendriks
Coalition for Epidemic Preparedness Innovations
·
Coalition for Epidemic Preparedness Innovations
Medicine
6.52k
citations
29
h-index
38
Aachen papers
▲
Leslie van der Fits
Johnson & Johnson (United States)
·
Johnson & Johnson (Netherlands)
Medicine
6.32k
citations
32
h-index
17
Aachen papers
▲
Mathieu Le Gars
Janssen (Netherlands)
·
Johnson & Johnson (Netherlands)
Medicine
6.2k
citations
22
h-index
42
Aachen papers
▲
Jerome H. H. V. Custers
Janssen (Netherlands)
·
Johnson & Johnson (Netherlands)
Biochemistry, Genetics and Molecular Biology
6.09k
citations
32
h-index
21
Aachen papers
▲
Frank Wegmann
Janssen (Netherlands)
Medicine
5.95k
citations
28
h-index
34
Aachen papers
▲
Mandy A. C. Jongeneelen
Johnson & Johnson (United States)
·
Johnson & Johnson (Netherlands)
Biochemistry, Genetics and Molecular Biology
5.93k
citations
21
h-index
7
Aachen papers
▲
Núria Guimerà
Johnson & Johnson (United States)
·
DDL Diagnostic Laboratory
Medicine
5.84k
citations
19
h-index
4
Aachen papers
▲
Georgi Shukarev
Medicine
5.42k
citations
18
h-index
21
Aachen papers
▲
Vicky Cárdenas
GlaxoSmithKline (United States)
·
Aurum Institute
Medicine
5.42k
citations
23
h-index
1
Aachen papers
▲
Julie A. Ake
Walter Reed Army Institute of Research
Medicine
5.4k
citations
37
h-index
1
Aachen papers
▲
Annemart Koornneef
Janssen (Netherlands)
Agricultural and Biological Sciences
4.71k
citations
19
h-index
8
Aachen papers
▲
Kourtney J. Davis
Johnson & Johnson (United States)
·
Janssen Research & Development (United States)
Medicine
4.44k
citations
35
h-index
1
Aachen papers
▲
An Vandebosch
Argenx (Belgium)
Medicine
4.22k
citations
22
h-index
1
Aachen papers
▲
Olivier Godeaux
Medicine
4.08k
citations
18
h-index
1
Aachen papers
▲
Kanika Vanshylla
Johnson & Johnson (Netherlands)
Medicine
3.93k
citations
29
h-index
2
Aachen papers
▲
Boerries Brandenburg
Johnson & Johnson (United States)
·
Johnson & Johnson (Netherlands)
Medicine
3.9k
citations
23
h-index
10
Aachen papers
1–30 of 146
Page 1 / 5
Next →
Papers
110
Search
Sort
Most cited
Newest
Oldest
Patent citations
Title
Any type
article
review
book-chapter
conference-paper
preprint
dissertation
book
dataset
other
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
Open access
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
2021
Nature
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
cited by 2 patents
314
citations
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
2021
JAMA
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
cited by 2 patents
305
citations
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
2022
New England Journal of Medicine
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
243
citations
Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
2021
New England Journal of Medicine
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
cited by 1 patent
236
citations
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
2023
New England Journal of Medicine
article
Medicine
Respiratory viral infections research
Open access
153
citations
Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
2020
medRxiv
preprint
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
141
citations
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer
2021
New England Journal of Medicine
article
Medicine
Heparin-Induced Thrombocytopenia and Thrombosis
Open access
119
citations
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years
2020
The Journal of Infectious Diseases
article
Medicine
Respiratory viral infections research
cited by 9 patents
111
citations
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques
2023
Nature
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
cited by 2 patents
104
citations
Geographic and Population Distributions of Human Immunodeficiency Virus (HIV)–1 and HIV-2 Circulating Subtypes: A Systematic Literature Review and Meta-analysis (2010–2021)
2023
The Journal of Infectious Diseases
review
Immunology and Microbiology
HIV Research and Treatment
Open access
97
citations
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
2022
Nature Microbiology
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
91
citations
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
2020
The Lancet HIV
article
Immunology and Microbiology
HIV Research and Treatment
Open access
cited by 3 patents
88
citations
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment
2020
Vaccine
article
Biochemistry, Genetics and Molecular Biology
Virus-based gene therapy research
Open access
cited by 2 patents
84
citations
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
2022
The Lancet Infectious Diseases
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
84
citations
Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers
2020
Cell Reports
article
Medicine
Viral Infections and Outbreaks Research
Open access
cited by 15 patents
80
citations
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine
2021
Annals of Internal Medicine
article
Medicine
Mosquito-borne diseases and control
80
citations
A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands
2020
Movement Disorders
article
Medicine
Lysosomal Storage Disorders Research
Open access
cited by 2 patents
75
citations
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
2021
PLoS Medicine
article
Medicine
Viral Infections and Outbreaks Research
Open access
cited by 1 patent
69
citations
EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia
2020
Annals of Neurology
article
Medicine
Neurological disorders and treatments
Open access
68
citations
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
2022
PLoS Medicine
article
Medicine
Viral Infections and Outbreaks Research
Open access
65
citations
1–20 of 110
Page 1 / 6
Next →